menu
    • menu

    Company profile for Frontier Biotechnologies

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Our medicines typically address the unmet medical needs of patients in the areas of a...
    Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Our medicines typically address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management.. Two additional drug candidates are currently undergoing multiple clinical trials in Phase I and Phase II in both China and the United States.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Frontier BiotechnologiesChina Flag
    Country
    Country
    China
    Address
    Address
    Nanjing, Jiangsu 210041, CN
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.frontierbiotech.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/frontier-biotechnologies-inc/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Frontier Biotech Gains After China Permits Inhaled Covid-19 Drug to Start Trials
    Frontier Biotech Gains After China Permits Inhaled Covid-19 Drug to Start Trials

    27 Sep 2022

    // YICAIGLOBAL

    https://www.yicaiglobal.com/news/frontier-biotech-gains-after-china-permits-inhaled-covid-19-drug-to-start-trials

    YICAIGLOBAL
    27 Sep 2022
    Share Share
    Frontier reports positive Phase I Covid-19 drug data
    Frontier reports positive Phase I Covid-19 drug data

    08 Aug 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/frontier-covid-drug-trial/

    CLINICALTRIALSARENA
    08 Aug 2022
    Share Share
    FRONTIER BIOTECH ANNOUNCES POSITIVE PI RESULTS OF CORONAVIRUS MPRO SM INHIBITOR
    FRONTIER BIOTECH ANNOUNCES POSITIVE PI RESULTS OF CORONAVIRUS MPRO SM INHIBITOR

    08 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/frontier-biotechnologies-announces-positive-phase-1-results-of-its-first-coronavirus-main-protease-mpro-small-molecule-inhibitor-laying-foundation-for-the-treatment-of-acute-and-long-covid-301601537.html

    PRNEWSWIRE
    08 Aug 2022
    Share Share
    AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
    AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

    22 Dec 2021

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/affiris-and-frontier-biotechnologies-announce-license-agreement-for-affitopeat04-an-active-immunotherapy-targeting-pcsk9-to-treat-hypercholesterolemia-in-greater-china-1642055496.pdf

    PRESS RELEASE
    22 Dec 2021
    Share Share
    Frontier Biotech' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen
    Frontier Biotech' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen

    27 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/frontier-biotechnologies-long-acting-injectable-aikeningr-in-a-two-drug-regimen-proves-safe-and-effective-for-critically-ill-hospitalized-aids-patients-301409816.html

    PRNEWSWIRE
    27 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search